Effectiveness Study Low-Dose Naltrexone Versus ARV's for HIV+
NCT01174914
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
171
Enrollment
OTHER
Sponsor class
Conditions
HIV Seropositivity
Interventions
OTHER:
ARV's + Placebo
DRUG:
Naltrexone
DRUG:
Naltrexone + ARV's
Sponsor
The Ojai Foundation